Quiz: Radionuclide Therapy A multiple-choice quiz consists of: 10 QuestionsQuestions are selected randomly from a collection of 17 questions. More Questions You will get deferent questions every time you take the quiz. Correct AnswersThere could be more than one correct answer, select all that apply.Skip QuestionsYou are allowed to scroll backward and forward before submitting your answers.10 MinutesThe quiz has a time limit. Time's up You can still submit your answers after the allowed period of time has ended . When ready, click Next to start the quiz. Name (Required) Email (Optional) Twitter (Optional) 1. The hematologic toxicity of Y-90 Zevalin therapy is common. All of the following can be a sign of hematologic toxicity EXCEPT: Bruising Arrhythmia Fever Anemia None 2. Which of the following radioisotopes approved used in the treatment of bone metastases has a significant gamma emission and can be used both for imaging and therapy? P-32 Sr-89 Ra-223 Sm-153 None 3. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan Reviewing potential interfering medications Blocking thyroid uptake of free radioiodine Performing pulmonary function tests None 4. The form of targeted radionuclide therapy that uses a monoclonal antibody to deliver localized radiation is called: Radiation therapy. Radioimmunotherapy. Antibody therapy. Radiochemotherapy. None 5. A lone “cold” nodule in an otherwise normal thyroid gland warrants: Chemotherapy. Fine needle aspiration biopsy. Radiation therapy. Surgical removal. None 6. Which of the following property of radiation is principally used in the treatment of tumors? Chemical effect Fluorescent effect Photographic effect Biologic effect None 7. Which of the following time is advised for patients treated with 1-131 to delay conception after treatment? 2 months 4 months 1 month 6 months None 8. According to the Society of Nuclear Medicine “SNM Procedure Guideline for Therapy of Thyroid Disease with I-131 (Sodium Iodide),” typically administered activity for treatment of presumed thyroid cancer in the neck or mediastinal lymph nodes is in the range: 100–150 mCi. 50–100 mCi. 200–250 mCi. 150–200 mCi. None 9. An ultimate treatment for patients who are nonresponsive to or cannot tolerate other available therapies for a particular illness and whose prognosis is often poor is called: Consolidation therapy. Standard therapy. Salvage therapy. Retreatment. None 10. Transient increase in tracer uptake in responding metastases in the early months after chemotherapy/hormone therapy for breast and prostate cancer is called: Super scan. Super phenomenon. Flare phenomenon. Flare scan. None 1 out of 10 Time's upTime is Up! By Nasser AlMutairi|2021-09-20T13:15:38+03:00April 26th, 2021|Radionuclide Therapy| Share This Post With Others! FacebookXLinkedInWhatsAppPinterestEmail About the Author: Nasser AlMutairi Senior Nuclear Medicine Specialist at Hafar Al-Batin Central Hospital, Founder of NuclearMed Website. One Comment Muawia Ibrahim Elgak January 10, 2025 at 6:37 pm - Reply Thank you for your questions Leave a ReplyCancel reply
Thank you for your questions